Visit website
Datix

Investment April 2008

SectorHealthcare and Life SciencesTechnology

Business Healthcare Software

Growth StrategyProduct and Service DevelopmentInternational Expansion

Why we invested

Risk management systems are a regulatory requirement for healthcare institutions, and the increasing levels of both regulation and litigation are driving growth in domestic and overseas markets. This was an opportunity to help the leading company in its field capitalise on these growth opportunities, by investing in new product innovation and expansion into overseas markets.

Overseas sales growth

40% p.a.

The result

During the five years of our ownership, Datix significantly expanded its operations into new vertical markets and geographic regions, extending its reach to protect over 80 million people. This included the roll-out of its software by the US Department of Defense in its Military Health System, and by other major providers of healthcare services in the US, Canada, Europe, Australia and the Middle East.

In July 2013, the company was sold to a management buy-out funded by a consortium of private investors.

Bowmark was very supportive and really bought into our plans, providing help and assistance with our strategy, as well as some valuable ideas for new direction. Jonathan Hazan,Chief Executive

Read more about our Healthcare and Life Sciences strategy

Find out more